Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
PHASERX, INC. (PZRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2018 8-K Other Events
02/01/2018 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
02/01/2018 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
Docs: "Asset Purchase Agreement, between PhaseRx, Inc. and Roivant Sciences GmbH"
01/24/2018 8-K Other Events
01/18/2018 8-K Other Events
01/10/2018 8-K Other Events
12/15/2017 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "PhaseRx Receives Decision from the Nasdaq Hearings Panel for Continued Listing of Shares"
11/28/2017 8-K Other Events, Financial Statements and Exhibits
Docs: "PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from European Medicines Agency"
11/09/2017 8-K Quarterly results
Docs: "PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
10/31/2017 8-K Quarterly results
10/13/2017 8-K Quarterly results
09/26/2017 8-K Quarterly results
09/20/2017 8-K Quarterly results
09/08/2017 8-K Quarterly results
08/24/2017 8-K Quarterly results
08/10/2017 8-K Quarterly results
Docs: "PhaseRx Reports Second Quarter 2017 Financial Results and Provides Corporate Update"
05/26/2017 8-K Form 8-K - Current report
05/12/2017 8-K Form 8-K - Current report
03/27/2017 8-K Form 8-K - Current report
03/08/2017 8-K Form 8-K - Current report
03/06/2017 8-K Form 8-K - Current report
11/28/2016 8-K Form 8-K - Current report
11/08/2016 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Slide Presentation of Non-Human Primate Safety Study Data of PhaseRx, Inc.",
"PhaseRx Announces Positive Safety Results from Large Animal Study with Hybrid mRNA Delivery Technology"
11/07/2016 8-K Quarterly results
Docs: "PhaseRx Reports Third Quarter 2016 Financial Results and Provides Corporate Update"
08/24/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/02/2016 8-K Quarterly results
Docs: "PhaseRx Reports Second Quarter 2016 Financial Results and Provides Corporate Update"
06/21/2016 8-K Other Events, Financial Statements and Exhibits
Docs: "PhaseRx Advances Product Pipeline for Treatment of Rare Genetic Liver Diseases"
06/09/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan and Security Agreement",
"Warrant Agreement"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy